Business Description
![Arvinas Inc Arvinas Inc logo](https://static.gurufocus.com/logos/0C0000BIBF.png?14)
Arvinas Inc
NAICS : 325412
SIC : 2834
ISIN : US04335A1051
Description
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 449.73 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.11 | |||||
Beneish M-Score | -1.36 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 29.2 | |||||
3-Year EBITDA Growth Rate | -34 | |||||
3-Year EPS without NRI Growth Rate | -29.9 | |||||
3-Year FCF Growth Rate | -37.5 | |||||
3-Year Book Growth Rate | -9.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 12.44 | |||||
Future 3-5Y Total Revenue Growth Rate | 47.91 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.73 | |||||
9-Day RSI | 40.19 | |||||
14-Day RSI | 38.08 | |||||
6-1 Month Momentum % | -31.16 | |||||
12-1 Month Momentum % | 12.94 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.94 | |||||
Quick Ratio | 4.94 | |||||
Cash Ratio | 4.86 | |||||
Days Sales Outstanding | 28.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12 | |||||
Shareholder Yield % | 0.12 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -556.94 | |||||
Net Margin % | -497.62 | |||||
FCF Margin % | -499.3 | |||||
ROE % | -65.67 | |||||
ROA % | -30.4 | |||||
ROIC % | -165.72 | |||||
ROC (Joel Greenblatt) % | -2609.07 | |||||
ROCE % | -44.82 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 18.99 | |||||
PB Ratio | 2.79 | |||||
Price-to-Tangible-Book | 2.79 | |||||
EV-to-EBIT | -1.35 | |||||
EV-to-Forward-EBIT | -1.04 | |||||
EV-to-EBITDA | -1.37 | |||||
EV-to-Forward-EBITDA | -1.04 | |||||
EV-to-Revenue | 7.49 | |||||
EV-to-Forward-Revenue | 4.62 | |||||
EV-to-FCF | -1.5 | |||||
Price-to-Net-Current-Asset-Value | 2.89 | |||||
Price-to-Net-Cash | 3 | |||||
Earnings Yield (Greenblatt) % | -74.07 | |||||
FCF Yield % | -20.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ARVN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arvinas Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 71.3 | ||
EPS (TTM) ($) | -5.93 | ||
Beta | 1.9 | ||
Volatility % | 111.14 | ||
14-Day RSI | 38.08 | ||
14-Day ATR ($) | 1.51283 | ||
20-Day SMA ($) | 25.6945 | ||
12-1 Month Momentum % | 12.94 | ||
52-Week Range ($) | 13.57 - 53.08 | ||
Shares Outstanding (Mil) | 68.43 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Arvinas Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Arvinas Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Arvinas Inc Frequently Asked Questions
What is Arvinas Inc(ARVN)'s stock price today?
The current price of ARVN is $24.88. The 52 week high of ARVN is $53.08 and 52 week low is $13.57.
When is next earnings date of Arvinas Inc(ARVN)?
The next earnings date of Arvinas Inc(ARVN) is 2024-08-08 Est..
Does Arvinas Inc(ARVN) pay dividends? If so, how much?
Arvinas Inc(ARVN) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |